← Funding directory

Dated funding evidence

Apollo Therapeutics

Formation (JV) · £40M · 2016-01-25

Reported round£40MFormation (JV)
Disclosure date
2016-01-25
Reported currency
GBP
Companies House
13393274
Evidence sources
1

Company

Apollo TherapeuticsCH 13393274
2016-01-25Formation (JV)£40M

Record fields

What the source states

Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.

Round ID
FR-00027
Stage
Formation (JV)
Round name
Formation (JV)
Amount
£40M
Lead investors
AstraZeneca, GSK, Johnson & Johnson Innovation
Other investors
Cambridge Enterprise, Imperial Innovations, UCL Business
Source layers
VC research snapshot, Live Chris T D1
Snapshot
2026-08-15

Named evidence

Source trail

This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.

A 37X Ventures portfolio site

Operated by 37x Limited, a Guernsey Non Cellular Company, company number CMP76157, incorporated 18 July 2025.

Registered office: Les Echelons Court, Les Echelons, St. Peter Port, Guernsey, GY1 1AR.

Full company details